RenovoRx, Inc.
RNXT · XNASCIK 1574094fmd_1XJ81AMNBG6JDVZW8GSJ6JZYWMManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2020 to Sep 30, 2026, 27 periods
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Total revenues | – | – | – | – | 0 | 1 |
| Net interest income | (1) | (1) | – | – | – | – |
| Cost of revenue | – | – | – | – | 0 | 0 |
| Gross profit | – | – | – | – | 0 | 1 |
| Research and development | 2 | 3 | 4 | 6 | 6 | 6 |
| Selling, general and administrative | – | – | – | 6 | 5 | 7 |
| Total operating expenses | 3 | 6 | 10 | 11 | 11 | 13 |
| Operating income | (3) | (6) | (10) | (11) | (11) | (13) |
| Other non-operating income (expense) | (1) | (1) | 0 | 1 | 2 | 1 |
| Income before taxes | – | – | – | – | (9) | (11) |
| Income tax expense | – | – | – | – | – | 0 |
| Net income from continuing operations | – | – | – | – | – | (11) |
| Net income | (4) | (6) | (10) | (10) | (9) | (11) |